Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 2 Unknown 1 Recruiting 1 Completed 1

Sponsor Class

OTHER 4 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Immunoglobulin Light-chain Amyloidosis 1 Amyloidosis 1

Interventions

Cisplatin 15 Paclitaxel 14 Taxes 10 Cyclophosphamide 9 Carboplatin 9 Gemcitabine 7 Platinum 6 1,2-diaminocyclohexaneplatinum II citrate 6 Trastuzumab 5 Radiotherapy 5 Oxaliplatin 5 Doxorubicin 5 Docetaxel 5 Cytarabine 5 Capecitabine 5 Brachytherapy 5 fludarabine 4 Rituximab 4 Radiosurgery 4 Fluorouracil 4 Dexamethasone 4 Watchful Waiting 3 Radiotherapy, Intensity-Modulated 3 Pemetrexed 3 Nimorazole 3 Lenalidomide 3 Imatinib Mesylate 3 Idarubicin 3 Gene Expression Profiling 3 thymoglobulin 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × NETWORK × isatuximab × Clear all

NCT05066607 2024-03-06

IsAMYP

Intergroupe Francophone du Myelome

Phase 2 Unknown

Immunoglobulin Light-chain Amyloidosis, Amyloidosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡